The Evolution of Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy

Voramon  Teranasthiarphan; Thakerng  Pitakteerabundit; Nan-ak  Wiboonkhwan; Tortrakoon  Thongkan

doi:10.33192/Smj.2022.33

Authors

Voramon Teranasthiarphan Department of Surgery, Prince of Songkla University, Hat Yai, Songkhla
Thakerng Pitakteerabundit Department of Surgery, Prince of Songkla University, Hat Yai, Songkhla
Nan-ak Wiboonkhwan Department of Surgery, Prince of Songkla University, Hat Yai, Songkhla
Tortrakoon Thongkan Department of Surgery, Prince of Songkla University, Hat Yai, Songkhla

DOI:

https://doi.org/10.33192/Smj.2022.33

Keywords:

ALPPS, Future liver remnant, hepatectomy

Abstract

Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy is a cutting-edge surgical technique for resection of hepatic malignancies that has piqued the interest of the international hepatobiliary community. Patients with insufficient future liver remnants, many of whom are considered unresectable via other methods, have the possibility of being cured with this treatment. The main issues; howbeit include, increased perioperative morbidity and mortality as well as both early and rapid disease recurrence. However, with continuous improving of patient selection, optimizing stage 2 operation times and refined operative techniques this has led to reduced morbidity and mortality rates. As for its usage, the most frequent indication is colorectal liver metastasis (CRLM); in which, the results in CRLM have shown higher resectability; however, it has a comparable complication rate to two-stage hepatectomy. Conversely, perihilar cholangiocarcinoma and hepatocellular carcinoma have terrible outcomes; although, with technical refinement and better patient selection good outcomes are achievable. Herein, we summarized the current evidence based of the application of ALPPS in real-life practice, including the potential complications related to this procedure.

References

May BJ, Madoff DC. Portal Vein Embolization: Rationale, Technique, and Current Application. Semin Interv Radiol 2012;29:81–9.

Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-Stage Hepatectomy: A Planned Strategy to Treat Irresectable Liver Tumors. Ann Surg 2000;232:777–85.

Lam VWT, Laurence JM, Johnston E, Hollands MJ, Pleass HCC, Richardson AJ. A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal sliver metastases. HPB 2013;15:483–91.

Giuliante F, Ardito F, Ferrero A, Aldrighetti L, Ercolani G, Grande G, et al. Tumor progression during preoperative chemotherapy predicts failure to complete 2-stage hepatectomy for colorectal liver metastases: Results of an Italian multicenter analysis of 130 patients. J Am Coll Surg 2014;219:285–94.

Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small for-size settings. Ann Surg 2012;255:405–14.

Schadde E, Raptis DA, Schnitzbauer AA, Ardiles V, Tschuor C, Lesurtel M, et al. Prediction of Mortality After ALPPS Stage-1: An Analysis of 320 Patients From the International ALPPS Registry. Ann Surg 2015;262:780–5.

Liu Y, Yang Y, Gu S, Tang K. A systematic review and metaanalysis of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) versus traditional staged hepatectomy. Medicine (Baltimore) 2019;98:e15229.

Shindoh J, Vauthey J-N, Zimmitti G, Curley SA, Huang SY, Mahvash A, et al. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg 2013;217:126–33; discussion 133-134.

Abbasi A, Rahnemai-Azar AA, Merath K, Weber SM, Abbott DE, Dillhoff M, et al. Role of associating liver partition and portal vein ligation in staged hepatectomy (ALPPS)—strategy for colorectal liver metastases. Transl Gastroenterol Hepatol 2018;3:66.

Lang H, Baumgart J, Mittler J. Associated Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Registry: What Have We Learned? Gut Liver 2020;14:699–706.

Matsuo K, Murakami T, Kawaguchi D, Hiroshima Y, Koda K, Yamazaki K, et al. Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization. Surgery 2016;159:1289–98.

Bertens KA, Hawel J, Lung K, Buac S, Pineda-Solis K, Hernandez-Alejandro R. ALPPS: Challenging the concept of unresectability – A systematic review. Int J Surg;13:280–7.

Hernandez-Alejandro R, Bertens KA, Pineda-Solis K, Croome KP. Can we improve the morbidity and mortality associated with the associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure in the management of colorectal liver metastases? Surgery 2015;157:194–201.

Petrowsky H, Györi G, de Oliveira M, Lesurtel M, Clavien P-A. Is partial-ALPPS safer than ALPPS? A single-center experience. Ann Surg 2015;261:e90-92.

Ardiles V, Schadde E, Santibanes E, Clavien PA. Commentary on “Happy marriage or ‘dangerous liaison’: ALPPS and the anterior approach.” Ann Surg 2014;260:e4.

Dokmak S, Belghiti J. Which limits to the “ALPPS” approach? Ann Surg 2012;256:e6.

Alvarez FA, Ardiles V, de Santibañes M, Pekolj J, de Santibañes E. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy Offers High Oncological Feasibility With Adequate Patient Safety: A Prospective Study at a Single Center. Ann Surg 2015;261:723–32.

Truant S. Laparoscopic Partial ALPPS: Much Better Than ALPPS! Ann Hepatol 2019;18:269-273.

Chan ACY, Chok K, Dai JWC, Lo CM. Impact of split completeness on future liver remnant hypertrophy in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma: Complete-ALPPS versus partial-ALPPS. Surgery 2017;161:357–64.

Wu X, Rao J, Zhou X, Deng R, Ma Y. Partial ALPPS versus complete ALPPS for staged hepatectomy. BMC Gastroenterol 2019;19:170.

Robles R, Parrilla P, López-Conesa A, Brusadin R, de la Peña J, Fuster M, et al. Tourniquet modification of the associating liver partition and portal ligation for staged hepatectomy procedure. Br J Surg 2014;101:1129–34.

López-López V, Robles-Campos R, Brusadin R, López-Conesa A, Navarro Á, Arevalo-Perez J, et al. Tourniquet-ALPPS is a promising treatment for very large hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Oncotarget 2018;9:28267–80.

Chan ACY, Poon RTP, Lo CM. Modified Anterior Approach for the ALPPS Procedure: How We Do It. World J Surg 2015;39:2831–5.

Li J, Moustafa M, Linecker M, Lurje G, Capobianco I, Baumgart J, et al. ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study. Ann Surg Oncol 2020;27:1372–84.

Schadde E, Ardiles V, Robles-Campos R, Malago M, Machado M, Hernandez-Alejandro R, et al. Early survival and safety of ALPPS: first report of the International ALPPS Registry. Ann Surg 2014;260:829–36.

Moris D. Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis. World J Surg 2018;42:806-815.

Røsok BI, Høst-Brunsell T, Brudvik KW, Carling U, Dorenberg E, Björnsson B, et al. Characterization of early recurrences following liver resection by ALPPS and two stage hepatectomy in patients with colorectal liver-metastases and small future liver remnants; a translational substudy of the LIGRO-RCT. HPB 2019;21:1017–23.

Aloia TA, Vauthey J-N. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost? Ann Surg 2012;256:e9.

Margonis GA, Sergentanis TN, Ntanasis-Stathopoulos I, Andreatos N, Tzanninis I-G, Sasaki K, et al. Impact of Surgical Margin Width on Recurrence and Overall Survival Following R0 Hepatic Resection of Colorectal Metastases: A Systematic Review and Meta-analysis. Ann Surg 2018;267:1047–55.

Serenari M, Alvarez FA, Ardiles V, de Santibañes M, Pekolj J, de Santibañes E. The ALPPS Approach for Colorectal Liver Metastases: Impact of KRAS Mutation Status in Survival. Dig Surg 2018;35:303–10.

Sandström P, Røsok BI, Sparrelid E, Larsen PN, Larsson AL, Lindell G, et al. ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial). Ann Surg 2018;267:833–40.

Schnitzbauer AA, Schadde E, Linecker M, Machado MA, Adam R, Malago M, et al. Indicating ALPPS for Colorectal Liver Metastases: A Critical Analysis of Patients in the International ALPPS Registry. Surgery 2018;164:387–94.

D’Haese JG, Neumann J, Weniger M, Pratschke S, Björnsson B, Ardiles V, et al. Should ALPPS be Used for Liver Resection in Intermediate-Stage HCC? Ann Surg Oncol 2016;23:1335–43.

Vennarecci G, Laurenzi A, Levi Sandri GB, Busi Rizzi E, Cristofaro M, Montalbano M, et al. The ALPPS procedure for hepatocellular carcinoma. EJSO 2014;40:982–8.

Chan ACY, Poon RTP, Chan C, Lo CM. Safety of ALPPS Procedure by the Anterior Approach for Hepatocellular Carcinoma. Ann Surg 2016;263:e14–6.

Wang Z, Peng Y, Hu J, Wang X, Sun H, Sun J, et al. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Unresectable Hepatitis B Virus-related Hepatocellular Carcinoma: A Single Center Study of 45 Patients. Ann Surg 2020;271:534–41.

Chan A, Zhang WY, Chok K, Dai J, Ji R, Kwan C, et al. ALPPS Versus Portal Vein Embolization for Hepatitis-related Hepatocellular Carcinoma: A Changing Paradigm in Modulation of Future Liver Remnant Before Major Hepatectomy. Ann Surg 2021;273:957–65.

Olthof PB, Coelen RJS, Wiggers JK, Groot Koerkamp B, Malago M, Hernandez-Alejandro R, et al. High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry. HPB 2017;19:381–7.